Therapeutically, aspirin combined with HDM inhibitors, ICAM3 downstream signaling Src/PI3K inhibitors, or ICAM3/LFA-1 inhibitors (Lifitegrast), as well as ibuprofen combined with HDAC/HDM inhibitors, prevent cancer progression in vivo45, 46. Here, ITGB2 is linked to cancer.